These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8194900)

  • 1. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9.
    Kohno N; Inoue Y; Hamada H; Fujioka S; Fujino S; Yokoyama A; Hiwada K; Ueda N; Akiyama M
    Int J Cancer Suppl; 1994; 8():81-3. PubMed ID: 8194900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma.
    Hamada H; Kohno N; Hiwada K
    Jpn J Cancer Res; 1994 Feb; 85(2):211-9. PubMed ID: 8144402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay.
    Kohno N; Kyoizumi S; Tanabe M; Oyama T; Vossler M; Yamakido M; Akiyama M
    Cancer Res; 1989 Jun; 49(12):3412-9. PubMed ID: 2655895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating KL-6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma.
    Inata J; Hattori N; Yokoyama A; Ohshimo S; Doi M; Ishikawa N; Hamada H; Kohno N
    Int J Cancer; 2007 Jun; 120(12):2643-9. PubMed ID: 17294451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma.
    Gad A; Tanaka E; Matsumoto A; Wahab MA; Serwah Ael-H; Attia F; Ali K; Hassouba H; el-Deeb Ael-R; Ichijyo T; Umemura T; Muto H; Yoshizawa K; Kiyosawa K
    World J Gastroenterol; 2005 Nov; 11(42):6607-12. PubMed ID: 16425352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel monoclonal antibody, H9, directed against the core protein of MUC1 mucin.
    Hamada H; Kohno N; Yokoyama A; Kondo K; Yang SZ; Hiwada K; Watanabe K; Miyake M
    Oncol Rep; 2000; 7(2):225-32. PubMed ID: 10671662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KL-6: a serum marker for interstitial pneumonia.
    Kobayashi J; Kitamura S
    Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation.
    Ashida T; Higashishiba M; Sumimoto Y; Sano T; Miyazato H; Shimada T; Miyatake J; Kawanishi K; Tatsumi Y; Kanamaru A
    Int J Hematol; 2001 Dec; 74(4):464-8. PubMed ID: 11794706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
    Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
    Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
    Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
    J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6.
    Kohno N; Kyoizumi S; Awaya Y; Fukuhara H; Yamakido M; Akiyama M
    Chest; 1989 Jul; 96(1):68-73. PubMed ID: 2661160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis.
    Goto K; Kodama T; Sekine I; Kakinuma R; Kubota K; Hojo F; Matsumoto T; Ohmatsu H; Ikeda H; Ando M; Nishiwaki Y
    Lung Cancer; 2001 Oct; 34(1):141-8. PubMed ID: 11557124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis.
    Inoue Y; Nishimura K; Shiode M; Akutsu H; Hamada H; Fujioka S; Fujino S; Yokoyama A; Kohno N; Hiwada K
    Tuber Lung Dis; 1995 Jun; 76(3):230-3. PubMed ID: 7548906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological pancreatic tumor markers and the MUC1 apomucin.
    Ho JJ; Kim YS
    Pancreas; 1994 Nov; 9(6):674-91. PubMed ID: 7846010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy.
    Sakuma T; Takahashi K; Ohya N; Usuda K; Handa M
    Surg Today; 1999; 29(2):121-8. PubMed ID: 10030736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.
    Yamane K; Ihn H; Kubo M; Yazawa N; Kikuchi K; Soma Y; Tamaki K
    J Rheumatol; 2000 Apr; 27(4):930-4. PubMed ID: 10782818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating KL-6 levels in patients with drug induced pneumonitis.
    Ohnishi H; Yokoyama A; Yasuhara Y; Watanabe A; Naka T; Hamada H; Abe M; Nishimura K; Higaki J; Ikezoe J; Kohno N
    Thorax; 2003 Oct; 58(10):872-5. PubMed ID: 14514942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
    Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
    Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.